Not yet taking people in Hollandia2. fázis
RuxoTam; A phase II study to evaluate safety and efficacy of tamoxifen in combination with Ruxolitinib in patients with myelofibrosis
Key facts
- Where
- Groningen, HollandiaSee the site
- Phase
- 2. fázis
Where in Hollandia
- Universitair Medisch Centrum GroningenGroningen, HollandiaToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Medisch Centrum Groningen
- Trial code
- EU 2024-510926-19-00
- Record updated
- 2025. november 11.